Popular on Rezul
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- L2 Aviation Names Human Resource Veteran Warren Orr as Human Resources Leader
- When Is Following The Property Management Crowd The Right Choice?
- Miller Homes Marks Historic Moment in Leeds Village
- ICI Homes and David Weekley Homes Acquire Skinner Family Property
- Drawbridge Realty acquires IQVIA headquarters in North Carolina's Research Triangle Park
- Julington Group Joins Florida Homes Realty & Mortgage
- Grammy nominated, Multiplatinum Producer "Khao" partners with tech company to create Christmas album for families to engage amid Covid-19
- Mizner Country Club's Vernon Gettone Achieves CRSE Certification
- Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
Similar on Rezul
- BoatDealers.ca Surges with Record Traffic in 2020
- 'Aesthetic Institute of Massachusetts' Announces Rebranding to 'Aesthetic Mentor'
- Code18 Interactive Launches New Websites for Balmex and Balmex Adult
- Grassroots Advocacy Group Urges Biden Administration to Appoint a Doctoral Level Mental Health Professional to Lead SAMHSA
- AUA College of Medicine Establishes Admissions Agreement with Mississippi Valley State University
- Be an Example, Get the Covid Shot
- "Diamond Fuji" to be Seen from TOKYO SKYTREE in February
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- SHELTER, New Works by Artists Byron Keith Byrd, Stefani Byrd, and Fenix Gallery Collective, January 20–February 24, 2021
- The Business Consultant behind The First Black-owned BP
Restech is proud to announce the launch of PepsinCheck, a PEPTEST product branded for the U.S. consumer market
Rezul News/10466813
America's first at-home reflux test can be ordered online at www.pepsincheck.com
HOUSTON - Rezul -- UK healthcare innovator, RD Biomed, developed Peptest, the world's first non-invasive test for reflux, in 2007. Since that time it has grown to global prominence. Shipping costs and wait times were a barrier to the U.S. market preventing the adoption of this direct to consumer diagnostic test. Now with Restech managing the PepsinCheck operations, the test is shipped from the U.S., processed at strategically located American labs, and results are sent back to the consumer by mail and a secure email within about a week.
Both PepsinCheck (U.S. market) and Peptest (non-U.S. markets) are manufactured by RD Biomed to the same global standard. The test detects the presence of the stomach enzyme pepsin (recognized as a reliable diagnostic biomarker for reflux) in saliva and sputum samples.
Restech VP of Clinical Affairs, Thomas Ball, commented, "As we Rethink Reflux across the continuum of care, direct to consumer healthcare plays a pivotal role. RD Biomed and the Peptest provide an ideal accompaniment to our product portfolio, ensuring that tough diagnostic cases find appropriate physician-based care in addition to broadening our reach to an unprecedented range of patients. PepsinCheck represents the first at-home reflux testing in the US market and holds the potential to revolutionize the care of individuals with symptoms ranging from heartburn, to chronic cough, and even obstructive sleep apnea."
More on Rezul News
Professor Peter Dettmar, Director of RD Biomed, said: "We're thrilled that our salivary pepsin test for diagnosing reflux has officially launched in the US. It has been a pleasure working with Restech, a successful digestive health solutions company, and we could not have chosen a better company to distribute and commercialise PepsinCheck by Peptest."
About Restech
At Restech, we believe there is a better way to manage reflux. Our team designed and launched the first real-time sensor that could function highly accurately in a non-liquid environment. Since then, we've obsessed over reflux, developing and seeking out new products across the diagnostic and therapeutic continuum. www.restech.com
About RD Biomed & Peptest
RD Biomed is a pharmaceutical development and diagnostic company based at Castle Hill Hospital in Hull, East Yorkshire. Innovators in healthcare product development, RD Biomed focusses on gastroenterology and wound management and develops products that identify, prevent and treat various medical conditions. www.peptest.co.uk
More on Rezul News
CONTACTS
Thomas Ball
Vice President of Clinical Affairs
T: 1.800.352.1512
E: tball@restech.com
Harvey Dettmar
Director, RD Biomed Limited
T: +44 1482 461866
E: harvey.dettmar@technostics.com
www.pepsincheck.com
Both PepsinCheck (U.S. market) and Peptest (non-U.S. markets) are manufactured by RD Biomed to the same global standard. The test detects the presence of the stomach enzyme pepsin (recognized as a reliable diagnostic biomarker for reflux) in saliva and sputum samples.
Restech VP of Clinical Affairs, Thomas Ball, commented, "As we Rethink Reflux across the continuum of care, direct to consumer healthcare plays a pivotal role. RD Biomed and the Peptest provide an ideal accompaniment to our product portfolio, ensuring that tough diagnostic cases find appropriate physician-based care in addition to broadening our reach to an unprecedented range of patients. PepsinCheck represents the first at-home reflux testing in the US market and holds the potential to revolutionize the care of individuals with symptoms ranging from heartburn, to chronic cough, and even obstructive sleep apnea."
More on Rezul News
- Code18 Interactive Launches New Websites for Balmex and Balmex Adult
- Patrick Finney of CJV Real Estate Closes A New Denver Area Property
- The Atlas Group adds Corbin Raines to their list of professional property managers
- Latino Leaders Network to Honor Tucson Mayor Regina Romero with the Antonio Villaraigosa Leadership Award at the 34th Tribute to Mayors
- Berkshire Hathaway HomeServices Florida Properties Group's 2020 Philanthropic Initiatives
Professor Peter Dettmar, Director of RD Biomed, said: "We're thrilled that our salivary pepsin test for diagnosing reflux has officially launched in the US. It has been a pleasure working with Restech, a successful digestive health solutions company, and we could not have chosen a better company to distribute and commercialise PepsinCheck by Peptest."
About Restech
At Restech, we believe there is a better way to manage reflux. Our team designed and launched the first real-time sensor that could function highly accurately in a non-liquid environment. Since then, we've obsessed over reflux, developing and seeking out new products across the diagnostic and therapeutic continuum. www.restech.com
About RD Biomed & Peptest
RD Biomed is a pharmaceutical development and diagnostic company based at Castle Hill Hospital in Hull, East Yorkshire. Innovators in healthcare product development, RD Biomed focusses on gastroenterology and wound management and develops products that identify, prevent and treat various medical conditions. www.peptest.co.uk
More on Rezul News
- The UK's Leading Digital Marketing Agency, Finsbury Media Announces Employees Will Be Allowed To Work From Home:
- IDeal Homes Real Estate Holdings Announces Four New Hires
- Celebrate the Model Grand Opening of Beacon Lake's Newest Builder, Toll Brothers, Feb. 13-14
- NMEA 2000 Development and Prototyping Boards for Marine Applications
- ICTBroadast Version 4.1, Advance call center software for your needs
CONTACTS
Thomas Ball
Vice President of Clinical Affairs
T: 1.800.352.1512
E: tball@restech.com
Harvey Dettmar
Director, RD Biomed Limited
T: +44 1482 461866
E: harvey.dettmar@technostics.com
www.pepsincheck.com
Source: Respiratory Technology Corporation
0 Comments
Latest on Rezul News
- Be an Example, Get the Covid Shot
- Eddie Wilder Named 50 Most Influential And Hall Of Fame Of 2020
- Former CEO & Founder of Five Star Custom Foods, Acquired by Cargill, Joins CEO Coaching International
- Thiel College names Terry Eddy to Board of Trustees
- Kuester Management Group Highlights Benefits of HOA Management for Small Associations
- Consolidated Contracting Forms "Consolidated Building Health" Division to Effectively Control the Spread of Diseases in Senior Living Communities
- "Diamond Fuji" to be Seen from TOKYO SKYTREE in February
- Q4 2020 | Houston Office | Research & Forecast Report
- Income Property Organization shares year end report
- The Hollows Condominium Association Selects Corner Property for Charming Development in Marlton, NJ
- Taryn Scherer Joins KW Realty, Poised to Transform Ann Arbor Real Estate with Targeted Marketing of Homes
- Texpak Offers Environmentally-Friendly Ecotach™ Fasteners to Address Sustainability Needs
- Morningstar names Quantified STF Fund top-performing tactical-allocation fund in 2020
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- HousingIQ Survey: Kentucky Housing Market Starts Year On Strong Note
- Jackson Village Condominium Association Chooses Corner Property for Development in Basking Ridge NJ
- Georgia Multiple Listing Service announces record production numbers by members in 2020
- SHELTER, New Works by Artists Byron Keith Byrd, Stefani Byrd, and Fenix Gallery Collective, January 20–February 24, 2021
- Hewitt receives SCR REALTOR® Distinguished Service Award
- Mizner Country Club's Vernon Gettone Achieves CRSE Certification